Skip to content

Neuranics Appoints Chief Financial Officer (CFO) to Support Next Phase of Growth

Less than 1 minute Minutes

Neuranics has strengthened the senior leadership team with the appointment of a Chief Financial Officer (CFO) as we enter the next phase of commercial growth. The appointment reflects our progression from intensive technology development towards wider commercial engagement on a global scale. It follows a strong start to 2026, marked by increasing international visibility and recognition for the company’s work.

This momentum has been reinforced by Neuranics being named among the UK’s Top 10 Startups in 2026 and receiving international recognition at CES 2026, were our technology was selected as a TechRadar Pro Top Picks Award winner. These milestones highlight growing global interest in Neuranics’ magnetic sensing solutions and the applications across wearables, extended reality (XR), and advanced human-machine interaction.

Jane Mackie has been appointed CFO, bringing more than 20 years of experience supporting high-growth technology companies through periods of scale and international expansion, with a background spanning acquisitions, corporate governance, financial management and fundraising.

Noel McKenna, CEO of Neuranics, said:

“I am delighted to welcome Jane to the team. Her experience supporting high-growth technology companies makes her a strong addition to Neuranics as we continue to scale the business globally.”

Jane Mackie, CFO at Neuranics, said:

“Neuranics is at a pivotal point as it transitions from deep technology development into a more commercially focused phase. I am excited to work with the team to build the financial and operational foundations needed to support global partnerships and long-term, sustainable growth.”

Neuranics are working with partners worldwide and see this appointment as a key step in building a scalable deep-tech business from Scotland with global reach. We also plan to expand our commercial team during 2026, with additional roles planned in both Glasgow and the United States to support growing international engagement.

Share this post:

Join our newsletter

Stay up to date with all of Neuranics key news, innovations, and much more.

Address

Rothesay House
134 Douglas Street
Glasgow G2 4HF
United Kingdom

Skip to content